A dataset quantifying polypharmacy in the United States

Polypharmacy is increasingly common in the United States, and contributes to the substantial burden of drug-related morbidity. Yet real-world polypharmacy patterns remain poorly characterized. We have counted the incidence of multi-drug combinations observed in four billion patient-months of outpati...

Descripción completa

Detalles Bibliográficos
Autores principales: Quinn, Katie J., Shah, Nigam H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Data Descriptor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663207/
https://www.ncbi.nlm.nih.gov/pubmed/29087369
http://dx.doi.org/10.1038/sdata.2017.167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663207/
https://www.ncbi.nlm.nih.gov/pubmed/29087369
http://dx.doi.org/10.1038/sdata.2017.167

Ejemplares similares